Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological response to clopidogrel in ischemic stroke: role of platelet alpha2-adrenergic receptors
2013-000313-20Phase 4Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clopidogrel in ischemic stroke, sponsored by CHU Saint-Etienne. Primary endpoint: Adrenergic component of platelet response by LTA. Started Apr 2014; status: completed.
02
Drugs
clopidogrel
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2013-000313-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000313-20.